Drug ingredient firm Arseus says margins to improve in 2013
BRUSSELS Feb 6 (Reuters) - Belgo-Dutch medical firm Arseus , the world's biggest seller of drug ingredients to pharmacists, expects its profit margin to improve this year after it beat profit expectations in 2012, it said on Wednesday.
It said its recurring core profit for 2012 was 87.4 million euros ($118.24 million), compared with 78.8 million expected on average by three banks and brokerages polled by Reuters. ($1 = 0.7392 euros) (Reporting By Ben Deighton)
- iPhone comes out of a 'bygone era', reviewers hail bigger handset
- Scots' support for independence lags on eve of referendum |
- Boeing, SpaceX win contracts to build 'space taxis' for NASA
- Fed may hint on rate-hike plan as it prepares for policy turn
- Islamic State campaign tests Obama's commitment to Mideast allies